IP Library Granted Patent US 8,439,861
Granted Patent B2
US 8,439,861 · App. 11/739,244 · Granted May 14, 2013

Skin penetrating touch fasteners

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,439,861
App. No.
11/739,244
Granted
May 14, 2013
Kind
B2
Abstract

A skin attachment member having first and second surface with a plurality of skin penetrating elements extending integrally from the first surface of the backing to a distal tip. The skin penetrating elements are sized to avoid contact with nerves below the epidermal skin layer and have a foam disposed between at least some of the skin penetrating elements. A method of using the skin attachment member to deliver a pharmaceutical composition through the skin.

Claims (23)

1. A skin attachment member comprising;

a backing having a first surface and a second surface;

a plurality of skin penetrating elements extending integrally from the first surface of the backing to a distal tip, the skin penetrating elements being sized to avoid contact with nerves below the epidermal skin layer; and

a foam disposed on the first surface of the backing, wherein at least a portion of the foam is disposed between at least some of the skin penetrating elements, wherein at least some of the skin penetrating elements each include a retention barb extending from an outer side surface of the skin penetrating element;

wherein at least a portion of the foam extends to a height greater than the height of at least some of the skin penetrating elements.

2. The member of claim 1 wherein a pharmaceutical composition is disposed within the foam.

3. The member of claim 2 wherein the pharmaceutical composition is in the formulation of a cream, a gel, or a liquid.

4. The member of claim 2 wherein the pharmaceutical composition comprises a biomolecule.

5. The member of claim 4 wherein the biomolecule is selected from the group consisting of a hormone or an antibody.

6. The member of claim 2 wherein the pharmaceutical composition comprises a molecule having a molecular weight greater than 500 Daltons.

7. The member of claim 2 wherein the pharmaceutical composition comprises a controlled release formulation.

8. The member of claim 2 wherein the pharmaceutical composition further comprises a vehicle.

9. The member of claim 1 wherein a plurality of the skin penetrating elements comprise a groove extending lengthwise from the base to the distal tip.

10. The member of claim 1 wherein the base comprises a plastic resin.

11. The member of claim 1 wherein the skin penetrating elements have a height of about 0.004 to about 0.040 inches.

12. The member of claim 1 wherein the skin penetrating elements have a height of about 0.012 inches.

13. The member of claim 1 wherein an adhesive is disposed on a surface of the foam.

14. The member of claim 2 wherein a skin penetration enhancer is disposed within the foam.

15. The member of claim 1 wherein the foam comprises PVC.

16. The member of claim 1 wherein the foam comprises PU.

17. The member of claim 1 , wherein the backing incorporates a bacterial killing agent.

18. The member of claim 17 , wherein the bacterial killing agent is silver.

19. The member of claim 1 , wherein a protective film covers at least part of an exterior surface of the foam.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2021
From: VELCRO BVBA
To: VELCRO IP HOLDINGS LLC
Reel/Frame 054891/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2016
From: VELCRO INDUSTRIES B.V.
To: VELCRO BVBA
Reel/Frame 038528/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2007
From: KINGSFORD, HOWARD A.
To: VELCRO INDUSTRIES B.V.
Reel/Frame 019226/0063 →